Skin Cancer Diagnostics and Therapeutics Market Report

China Skin Cancer Diagnostics and Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Oct 06, 2023
  • PAGES：236
  • REPORT CODE：GMM1831926
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth. North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk factors, a favorable reimbursement environment, and high adoption rate of novel technologies are primary factors behind the large market size. The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.

    This report elaborates on the current development of the Skin Cancer Diagnostics and Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • F Hoffmann-La Roche Ltd

    • Bristol-Myers Squibb Company

    • Merck & Co, Inc

    • Sun Pharmaceutical Industries Ltd

    By Type:

    • Melanoma

    • Non-melanoma

    By Application:

    • Hospital

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Skin Cancer Diagnostics and Therapeutics Market Overview 2018-2029

    • 1.1 China Skin Cancer Diagnostics and Therapeutics Industry Development Overview

    • 1.2 China Skin Cancer Diagnostics and Therapeutics Industry Development History

    • 1.3 China Skin Cancer Diagnostics and Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Skin Cancer Diagnostics and Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Skin Cancer Diagnostics and Therapeutics Production Volume, Production Value and Growth Rate of Melanoma (2018-2029)

      • 1.4.2 China Skin Cancer Diagnostics and Therapeutics Production Volume, Production Value and Growth Rate of Non-melanoma (2018-2029)

    • 1.5 China Skin Cancer Diagnostics and Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Skin Cancer Diagnostics and Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Skin Cancer Diagnostics and Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Skin Cancer Diagnostics and Therapeutics Market Analysis by Region

      • 1.6.1 North China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Skin Cancer Diagnostics and Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Skin Cancer Diagnostics and Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Skin Cancer Diagnostics and Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Skin Cancer Diagnostics and Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Skin Cancer Diagnostics and Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Skin Cancer Diagnostics and Therapeutics Industry Development

    Chapter 3 Skin Cancer Diagnostics and TherapeuticsIndustry Chain Analysis

    • 3.1 Skin Cancer Diagnostics and Therapeutics Industry Chain

    • 3.2 Skin Cancer Diagnostics and Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Skin Cancer Diagnostics and Therapeutics Market

    • 3.3 Skin Cancer Diagnostics and Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Skin Cancer Diagnostics and Therapeutics Market

    Chapter 4 China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 4.1 China Skin Cancer Diagnostics and Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Skin Cancer Diagnostics and Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Skin Cancer Diagnostics and Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Skin Cancer Diagnostics and Therapeutics Production Volume and Growth Rate of Melanoma

      • 4.5.2 China Skin Cancer Diagnostics and Therapeutics Production Volume and Growth Rate of Non-melanoma

    Chapter 5 China Skin Cancer Diagnostics and Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Skin Cancer Diagnostics and Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate of Hospital

      • 5.5.2 China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate of Others

    Chapter 6 China Skin Cancer Diagnostics and Therapeutics Market, by Region

    • 6.1 China Skin Cancer Diagnostics and Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Skin Cancer Diagnostics and Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Skin Cancer Diagnostics and Therapeutics Market Analysis

    • 7.1 North China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 7.2 North China Skin Cancer Diagnostics and Therapeutics Market, by Application

    Chapter 8 Central China Skin Cancer Diagnostics and Therapeutics Market Analysis

    • 8.1 Central China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 8.2 Central China Skin Cancer Diagnostics and Therapeutics Market, by Application

    Chapter 9 South China Skin Cancer Diagnostics and Therapeutics Market Analysis

    • 9.1 South China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 9.2 South China Skin Cancer Diagnostics and Therapeutics Market, by Application

    Chapter 10 East China Skin Cancer Diagnostics and Therapeutics Market Analysis

    • 10.1 East China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 10.2 East China Skin Cancer Diagnostics and Therapeutics Market, by Application

    Chapter 11 Northeast China Skin Cancer Diagnostics and Therapeutics Market Analysis

    • 11.1 Northeast China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 11.2 Northeast China Skin Cancer Diagnostics and Therapeutics Market, by Application

    Chapter 12 Southwest China Skin Cancer Diagnostics and Therapeutics Market Analysis

    • 12.1 Southwest China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 12.2 Southwest China Skin Cancer Diagnostics and Therapeutics Market, by Application

    Chapter 13 Northwest China Skin Cancer Diagnostics and Therapeutics Market Analysis

    • 13.1 Northwest China Skin Cancer Diagnostics and Therapeutics Market, by Type

    • 13.2 Northwest China Skin Cancer Diagnostics and Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 F Hoffmann-La Roche Ltd

        • 14.1.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.1.2 F Hoffmann-La Roche Ltd Skin Cancer Diagnostics and Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bristol-Myers Squibb Company

        • 14.2.1 Bristol-Myers Squibb Company Company Profile

        • 14.2.2 Bristol-Myers Squibb Company Skin Cancer Diagnostics and Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Merck & Co, Inc

        • 14.3.1 Merck & Co, Inc Company Profile

        • 14.3.2 Merck & Co, Inc Skin Cancer Diagnostics and Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sun Pharmaceutical Industries Ltd

        • 14.4.1 Sun Pharmaceutical Industries Ltd Company Profile

        • 14.4.2 Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics and Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Skin Cancer Diagnostics and Therapeutics Industry Research Conclusions

    • 15.2 Skin Cancer Diagnostics and Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Skin Cancer Diagnostics and Therapeutics Industry Market Size (2018-2029)

    • Figure China Skin Cancer Diagnostics and Therapeutics Production Volume, Production Value and Growth Rate of Melanoma (2018-2029)

    • Figure China Skin Cancer Diagnostics and Therapeutics Production Volume, Production Value and Growth Rate of Non-melanoma (2018-2029)

    • Figure China Skin Cancer Diagnostics and Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Skin Cancer Diagnostics and Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Skin Cancer Diagnostics and Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Skin Cancer Diagnostics and Therapeutics Market Share by Type in 2018

    • Figure China Skin Cancer Diagnostics and Therapeutics Market Share by Type in 2023

    • Figure China Skin Cancer Diagnostics and Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Production Volume and Growth Rate of Melanoma (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Production Volume and Growth Rate of Non-melanoma (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Market Share by Application in 2018

    • Figure China Skin Cancer Diagnostics and Therapeutics Market Share by Application in 2023

    • Figure China Skin Cancer Diagnostics and Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Production Volume by Region (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Production Value by Region (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Production Value Share by Region (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Sales Volume by Region (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Sales Value by Region (2018-2023)

    • Table China Skin Cancer Diagnostics and Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Skin Cancer Diagnostics and Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Skin Cancer Diagnostics and Therapeutics Production Volume by Type (2018-2023)

    • Table North China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Skin Cancer Diagnostics and Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Skin Cancer Diagnostics and Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Skin Cancer Diagnostics and Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Skin Cancer Diagnostics and Therapeutics Production Volume by Type (2018-2023)

    • Table South China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Skin Cancer Diagnostics and Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Skin Cancer Diagnostics and Therapeutics Production Volume by Type (2018-2023)

    • Table East China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Skin Cancer Diagnostics and Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Skin Cancer Diagnostics and Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Skin Cancer Diagnostics and Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Skin Cancer Diagnostics and Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Skin Cancer Diagnostics and Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Skin Cancer Diagnostics and Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Skin Cancer Diagnostics and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Skin Cancer Diagnostics and Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Skin Cancer Diagnostics and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Skin Cancer Diagnostics and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Skin Cancer Diagnostics and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Skin Cancer Diagnostics and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Industries Ltd Company Profile

    • Table Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics and Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US